Yes / Recent evidence suggests that the ion channel TRPA1 is implicated in lung adenocarcinoma (LUAD) where its role and mechanism of action remain unknown. We have previously established that the membrane receptor FGFR2 drives LUAD progression through aberrant protein-protein interactions mediated via its C-terminal proline rich motif. Here, we report that the N-terminal ankyrin repeats of TRPA1 directly bind to the C-terminal proline rich motif of FGFR2 inducing the constitutive activation of the receptor, thereby prompting LUAD progression and metastasis. Furthermore, we show that upon metastasis to the brain, TRPA1 gets depleted, an effect triggered by the transfer of TRPA1-targeting exosomal microRNA (miRNA-142-3p) from brain astrocytes to cancer cells. This downregulation, in turn, inhibits TRPA1-mediated activation of FGFR2 hindering the metastatic process. Our study reveals a direct binding event and characterizes the role of TRPA1 ankyrin repeats in regulating FGFR2-driven oncogenic process; a mechanism that is hindered by miRNA-142-3p. / Faculty of Biological Sciences at the University of Leeds, Wellcome Trust Seed Award, Royal Society Research Grant RG150100, MR/K021303/1, Swedish Research Council (2014-3801) and the Medical Faculty at Lund University.

In Tabak interagieren das Ankyrin-repeat Protein NtANK1 und der basische Leucin Zipper (bZIP)-Transkriptionsfaktor NtBZI-1. Diese Proteine sind in Auxin-vermittelter Genaktivierung und in Pathogenabwehr involviert. Ziel dieser Arbeit war es, die Funktion der homologen Ankyrin-repeat Proteine AKR2A und AKR2B aus Arabidopsis thaliana zu untersuchen. Dazu wurde die Interaktion zwischen AKR2A/B, und den homologen bZIP-Transkriptionsfaktoren der Gruppe C getestet. Mit verschiedenen Methoden, wie Hefe- und Protoplasten-two-hybrid und BiFC ( bimolecular fluorescence complementation ) konnte eine Interaktion der Arabidopsis Proteine nicht bestätigt werden. Lokalisationsstudien von YFP-AKR2A/B-Fusionsproteinen bestätigten, dass die Proteine im Cytoplasma lokalisiert sind. Sie besitzen ein funktionsfähiges Kernexportsignal und akkumulieren nach Inhibierung des Kernexports im Kern. Zur Funktionsaufklärung wurden AKR2-RNAi Pflanzen erzeugt, die sich phänotypisch vom Wildtyp unterscheiden: sie zeigen ein verringertes Wachstum und einen reduzierten Chlorophyllgehalt, abhängig von der Ausprägung des RNAi-Effektes. In elektronenmikroskopischen Untersuchungen ist zu erkennen, dass sich die Blattchloroplasten der AKR2-RNAi Pflanzen von denen des Wildtyps morphologisch unterscheiden und in ihrer Entwicklung unspezifisch beeinträchtigt sind. Eine Transkriptomanalyse der AKR2-RNAi Pflanzen zeigte, dass Gene des Endomembransystems herunterreguliert sind und viele Stress-induzierte Gene hochreguliert sind. Deshalb wurden die Pflanzen verschiedenen Stressbedingungen unterzogen und übereinstimmend stellte sich heraus, dass sie anfälliger gegenüber oxidativem Stress, Infektion mit dem biotrophen Bakterium Pseudomonas syringae und Infektion mit dem nekrotrophen Pilz Botrytis cinerea waren. Diese erhöhte Anfälligkeit kann als sekundärer Effekt aufgrund der beeinträchtigten Chloroplasten-Biogenese oder als spezifische Reaktion auf die reduzierte AKR2A/B-Proteinmenge interpretiert werden. Da AKR2A/B bereits als Importver mittler für chloroplastidäre Membranproteine beschrieben wurden (Bae et al., 2008), werden zusammenfassend mit den hier erhaltenen Daten multiple Funktionen für AKR2A und AKR2B diskutiert: Transport von Proteinen zu verschiedenen Endomembransystemen, eine Funktion im Signalaustausch zwischen Chloroplast und Kern, und eine Regulation der Transkriptionskontrolle im Kern.

TRPA1 is a thermosensitive ion channel from the ankyrin subfamily of Transient Receptor Potential (TRP) receptors. These proteins play essential roles in the transduction of wide variety of environmental and endogenous signals. TRPA1, which is abundantly expressed in primary nociceptive neurons, is an important transducer of various noxious and irritant stimuli and is also involved in the detection of temperature changes. Similarly to other TRP channels, TRPA1 is comprised of four subunits, each with six transmembrane segments (S1-S6), flanked by the cytoplasmic N- and C-terminal ends. In native tissues, TRPA1 is supposed to be regulated by multiple phosphorylation sites that underlie TRPA1 activity under physiological and various pathophysiological conditions. Using mutational approach, we predicted and explored the role of potential phosphorylation sites for protein kinase C in TRPA1 functioning. Our results identify candidate residues, at which phosho-mimicking mutations affected the channel's ability to respond to voltage and chemical stimuli, whereas the phospho-null mutations to alanine or glycine did not affect the channel activation. Particularly, we identify the serine 602 within the N-terminal ankyrin repeat domain 16, the substitution of which to aspartate completely abolished the TRPA1...

TRPA1 is a thermosensitive ion channel from the family of TRP (transient receptor potential) receptors. In primary sensory neurons, TRPA1 is an important transducer of painful stimuli, where it contributes to detection of noxious, irritant and inflammatory compounds of endogenous and exogenous origin. The major activation mode of TRPA1 is covalent modification of N-terminal cysteines or lysines by electrophilic compounds. The potency of the electrophilic agonists is increased by voltage dependency of the TRPA1 channel, which contributes substantially during membrane depolarization. To date, the role of several cysteine residues in the N- terminus has been demonstrated. However, the functional role of six cysteines in the transmembrane domain is still unknown. The first part of the thesis focuses on the functional role of the transmembrane cysteines in the activation of human TRPA1 channel. Our results indicate that these sites do not mediate reactive-electrophile-induced activation but four of the six cysteines substantially contribute to voltage-dependent gating of the channel and two participate in calcium-dependent modulation of TRPA1. In the second part of this thesis we aim to explore the proximity of two specific charged residues, located in the linker between the fourth and the fifth...

The tumour suppressor protein p16INK4a (p16) is a cyclin-dependent kinase (CDK) inhibitor that plays a key role in the regulation of the cell cycle by controlling the progression of cells through the G1 to S phase transition. Dysregulation of the protein through deletion, silencing or mutation of the gene encoding p16 is implicated in a range of different cancers including melanoma, cervical and oesophageal to name a few. p16 is composed of four ankyrin repeats and it has a very low thermodynamic and kinetic stability and rapidly unfolds even in the absence of denaturants. This low stability means that the protein is highly vulnerable to point mutations, which can result in functional inactivation through a range of different mechanisms such as deletion of key binding contacts, disruption of secondary or tertiary structure and consequent destabilisation leading to unfolding or aggregation. Heavy-chain antibodies are a unique form of antibody devoid of light chains found in the serum of the Camelid family (camels and llamas). Despite the absence of light chains, heavy-chain antibodies have evolved to complement traditional antibodies and retain the full binding capacity seen in canonical IgG antibodies. The single variable domain, known as a nanobody, is, at 15 kDa, the smallest antigen binding fragment, a tenth the size of a standard IgG antibody. The small size and relative ease of production, coupled with an unusually high stability, makes nanobodies useful tools as biological reagents, crystallography chaperones and therapeutics. The research contained within this PhD looks at the development of nanobodies to target p16. By leveraging the high stability of selected nanobodies, the aim was to obtain binders that could stabilise and reactivate a range of unstable cancer-associated mutants. The initial stages of the project focused on generating and optimising the expression and purification of p16 constructs prior to immunisation of animals to raise nanobodies. A high-throughput approach was taken to generate forty-five different p16 constructs with a range of different solubility and purification tags. These constructs were assessed in a multi-factorial expression screen, which resulted in the identification of a p16 construct with a ten-fold improvement in soluble expression levels compared with previous studies. A range of biophysical techniques, including circular dichroism and chemical denaturation, were performed to characterise this protein fully prior to immunisation. The second part of this project utilised a phage display library of two immune nanobody libraries generated against p16 and a p16 variant stabilised by previously published second-site mutations. This process yielded a large number of diverse nanobodies. Biophysical characterisation of these nanobodies was first performed, and they were found to have a range of chemical and thermal stabilities. Assays were then developed to test the ability of the nanobodies to stabilise p16. Two nanobodies were found to dramatically stabilise wild-type p16, with an increase in stability of approximately 44 % and 60 %, respectively. Furthermore, these nanobodies were also able to stabilise a subset of cancer-associated point mutants. Although there are NMR structures of p16, as well as a crystal structure of p16 bound to CDK6, the resolution of is very low, most likely due to the high backbone flexibility of p16. The last part of the project aimed to obtain a higher-resolution structure of p16 by using the two stabilising nanobodies as crystallisation chaperones. The more stabilising of the two nanobodies resulted in crystals that diffracted to a resolution of less than 2 $\AA$, a significant improvement compared with the previously published structure. In conclusion, a number of nanobodies were generated against tumour-associated p16 and shown to be capable of stabilising p16, allowing structure determination to high resolution and restoration of the stability of cancer-associated mutants to wild-type levels. In the project, a range of different approaches for nanobody production were explored, and these will be important for future applications. Moreover, the crystal structure of the p16-nanobody complex showed that the nanobody binds on the opposite face of p16, to the face involved in binding to CDKs; thus, this nanobody could potentially be exploited as a pharmacological chaperone to stabilise and restore the activity of cancer-associated mutant p16 in the cell.

<p>The spectrin-ankyrin network assembles diverse plasma membrane domains including axon initial segments and nodes of Ranvier, cardiomyocyte T-tubules and intercalated discs, epithelial lateral membranes, costameres and photoreceptor inner and outer segments. However the mechanism that targets the spectrin-ankyrin network to those plasma membrane domains is unknown. This thesis identifies two lipid inputs from protein palmitoylation and phosphoinositides that together control the precise localization of the spectrin-ankyrin network. In Chapter 2, we identify a linker peptide encoded by a single divergent exon that distinguishes the subcellular localization of ankyrin-B and -G by selectively suppressing protein binding through autoinhibition. In Chapter 3, we demonstrate that ankyrin-G is S-palmitoylated at a conserved C70 residue which is required to assemble epithelial lateral membranes and neuronal axon initial segments. We continue to interrogate how palmitoylation regulates ankyrin-G activities in Chapter 4, and identify DHHC5 and DHHC8 as the palmitoyltransferases in MDCK cells. We showed that palmitoylated ankyrin-G, in concert with phosphoinositide lipids, determines the polarized localization of beta II spectrin though a coincidence detection mechanism. This palmitoyltransferases/ ankyrin-G/beta II spectrin pathway determines the cell height of columnar epithelial cells. In Chapter 5, we elucidated the molecular mechanism through which the spectrin-ankyrin network assembles epithelial lateral membranes. We demonstrated that ankyrin-G and beta II spectrin function by opposing clathrin-mediated endocytosis to build the lateral membrane in MDCK cells. Together, this thesis dissects the mechanisms of how the spectrin-ankyrin network achieves precise membrane targeting and how it assembles lateral membranes to determine the morphogenesis of columnar epithelial cells, and provides the first molecular insight to understand how cells control the assembly of diverse plasma membrane domains.</p> / Dissertation

Thesis (Ph. D.)--University of Virginia, 2007. / Title from title page. Includes bibliographical references. Also available online through Digital Dissertations.

Orientador: Cláudia Herrera Tambeli / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-22T19:36:40Z (GMT). No. of bitstreams: 1 Bonet_IvanJoseMagayewski_M.pdf: 8243433 bytes, checksum: a5cdaab90bdcc5bbba66a0e5e4a1293f (MD5) Previous issue date: 2013 / Resumo: O Receptor Potencial Transiente Ankiryn 1 (TRPA1) é um canal não seletivo a cátions importante na fixação do limiar nociceptivos e pertencente à superfamília de canais TRP. É expresso em fibra C-nociceptiva e células não neuronais envolvidas na liberação de mediadores pró-inflamatórios. No presente estudo, investigamos se o TRPA1 contribui para a hiperalgesia induzida pela carragenina em ratos, e se essa contribuição é mediada por mecanismos de inflamação, tais como liberação de citocinas pró-inflamatórias e migração de neutrófilos e/ou sensibilização direta do neurônio aferente primário. Avaliamos a sensibilização do nociceptor induzida pela carragenina utilizando estímulos mecânico (analgesímetro mecânico) e químico (capsaicina), com ou sem bloqueio farmacológico local do receptor TRPA1 pelo seu antagonista seletivo HC 030031. A carragenina induziu hiperalgesia com pico na terceira hora, persistindo até vigésima quarta hora. O bloqueio farmacológico do receptor TRPA1 por co-administração de HC 030031 diminuiu significativamente a hiperalgesia induzida pela carragenina na terceira hora e a pós-administração de HC 030031 (2hrs 55min) reduziu na terceira e na sexta hora. O silenciamento do gene do TRPA1, induzido por um pré-tratamento intratecal com Oligonucleotídeo antisense, preveniu a hiperalgesia induzida pela carragenina após 24 horas além de reduzir significativamente a expressão de TRPA1 em células dos gânglios da raiz dorsal (GRD) (L5-6). O tratamento com carragenina, por sua vez, não alterou a expressão do receptor TRPA1 no GRD, e tampouco afetou os níveis de citocinas e a migração de neutrófilos no tecido periférico (patas). Concluímos que TRPA1 tem papel importante no desenvolvimento e manutenção da hiperalgesia inflamatória induzida pela carragenina por contribuir diretamente na excitabilidade do nociceptor. Baseado nesses achados, sugerimos que o bloqueio de TRPA1 é uma estratégia promissora no desenvolvimento de futuras drogas para o controle e tratamento da dor / Abstract: The Transient Receptor Potential Ankiryn 1 (TRPA1) is a nonselective cation channel, important in setting nociceptive threshold belonging to the superfamily of TRP channels. It is expressed in nociceptive C-fibers and in non-neuronal cells involved in pro-inflammatory mediators release. In this study, we asked whether TRPA1 contributes to carrageenan-induced hyperalgesia in rats, and whether this contribution is mediated by mechanisms in inflammation, such as cytokine release and neutrophil migration and/or by a direct sensitization of the primary afferent nociceptors. We measured the carrageenan-induced nociceptive sensitization using a mechanical (mechanical analgesymeter) and a chemical (capsaicin) stimulus, with or without pharmacological blockade of TRPA1 by its selective antagonist HC 030031. Carrageenan-induced Hiperalgesia has peaked at the third hour and persisted until the twenty-fourth hour. Pharmacological blockade of TRPA1 receptor by co-administration of HC 030031 significantly lowered carrageenan-induced hiperalgesia at the third hour and post-administration (2hrs 55min) decreased at both third and sixth hours. The neuronal TRPA1 gene silencing induced by intrathecal pre-treatment with antisense oligodoexynucleotide completely prevented carrageenan-induced hyperalgesia over 24 hours and significantly reduced TRPA1 expression in the dorsal root ganglia cells (DRG ) (L5-6). However, carrageenan treatment, did not affect the TRPA1 expression on DRG, neither affected the cytokines levels and neutrophil migration in peripheral tissue (paws). We conclude that TRPA1 plays an important role in the development and maintenance of carrageenan-induced inflammatory hyperalgesia by directly contributing to nociceptor excitability. Based on these findings, we suggest that TRPA1 blockade is a promising strategy for the development of future drugs to pain treatment and control / Mestrado / Fisiologia / Mestre em Biologia Funcional e Molecular

Scrub typhus is a potentially fatal infection that threatens one billion persons in the Asia-Pacific region and is caused by the obligate intracellular bacterium, Orientia tsutsugamushi. How this organism facilitates its intracellular survival and pathogenesis is poorly understood. Intracellular bacterial pathogens utilize the Type 1 (T1SS) or Type 4 secretion system (T4SS) to translocate ankyrin repeat-containing proteins (Anks) into the host cell to modulate host cell processes. The O. tsutsugamushi genome encodes one of the largest known bacterial Ank libraries as well as Type 1 and Type 4 secretion systems (T1SS and T4SS), which are expressed during infection. In silico analyses of the Anks’ C-termini revealed that they possess characteristics of T1SS secretion signals. Escherichia coli expressing a functional T1SS was able to secrete chimeric hemolysin proteins bearing the C-termini of 19 of 20 O. tsutsugamushi Anks. In addition to infecting endothelial cells, O. tsutsugamushi infects professional phagocytes. To better understand why these innate immune cells are unable to eliminate O. tsutsugamushi, we addressed the activity of host NF-κB proinflammatory transcription factor. Screening of O. tsutsugamushi infected cells at an MOI of 1 revealed inhibition of NF-κB nuclear accumulation as early as 8 hours in HeLa and bone-marrow derived macrophage cells. When stimulating infected cells with TNF-α, IκBα degradation still occurs, however NF-κB dependent gene transcription remains downregulated. Immunofluorescence microscopic analysis of TNF-α treated cells ectopically expressing all O. tsutsugamushi Anks revealed that two nuclear trafficking Anks, Ank1 and Ank6, result in a significant decrease in NF-κB nuclear accumulation. Additionally, these Anks also significantly inhibited NF-κB dependent gene transcription. Co-immunoprecipitation experiments revealed that both Anks interact with importin-β1, exportin-1, and the p65 NF-κB subunit. Treating cells with importazole significantly reduces the nuclear accumulation of Ank1 and Ank6. Finally, treating infected cells or cells ectopically expressing Ank1 or Ank6 with leptomycin B resulted in restoration of NF-κB nuclear accumulation. With these data, we propose that O. tsutsugamushi secretes Ank1 and Ank6 to initially interact with importin-β1, which permits their nuclear entry where they then interact with NF-κB and subsequently exportin-1 to prevent NF-κB nuclear accumulation.

Ankyrin receptor TRPA1 is an ion channel widely expressed on primary afferent sensory neurons, where it acts as a polymodal sensor of nociceptive stimuli. Apart from pungent chemicals (e. g. isothiocyanates, cinnamaldehyde and its derivatives, acrolein, menthol), it could be activated by cold temperatures, depolarizing voltages or intracellular calcium ions. TRPA1 channel is a homotetramer in which each subunit consists of cytoplasmic N and C termini and a transmembrane region. The transmembrane part is organized into six alpha- helices connected by intra- and extracellular loops. The N terminus comprises a tandem set of 16 to 17 ankyrin repeats (AR), while the C terminus has a substantially shorter, dominantly helical structure. In 2015, a partial cryo-EM structure of TRPA1 was resolved; however, the functional roles of the individual regions of the receptor have not yet been fully understood. This doctoral thesis is concerned to elucidate the role of highly conserved sequence and structural motifs within the cytoplasmic termini and the S4-S5 region of TRPA1 in voltage- and chemical sensitivity of the receptor. The probable binding site for calcium ions that are the most important physiological modulators of TRPA1 was described by using homology modeling, molecular-dynamics simulations,...